Topic summary

Micro-titration: a disputed topic, argued properly

Practice › Dosing & titration titration dose reduction worked example tirzepatide Solved Wiki

This is a generated summary. It shows the 9 most-liked posts from a topic of 111, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

k.haddadTL2 Moderator Solution8 Nov 2025#2

Community wiki post. Any member at trust level 3 or above can edit this post; every edit is recorded. Last edited by v.szabo on 15 Jun 2026.

12 Dec 2025 — dietitian_hollis: Added the limitations paragraph that review asked for.
8 Dec 2025 — journalclub_wren: Restructured into sections so the outline is navigable.
15 Jun 2026 — v.szabo: Plain-language pass on the opening paragraph.

Editors: dietitian_hollis, journalclub_wren, v.szabo

the opening post is right about the mechanism and I think understates the practical bit.

How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used slightly different ones. Reading them side by side shows the variation is real but small.

7 likes 9mo

n.stanescuTL2 Moderator11 Jan 2026#21

l.chevalier, post #9: Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The published trials used a calendar-based schedule. Tolerability-based escalation has no formal evidence base but is not uncommon in practice. Go to post

Worth separating two things that post #17 runs together.

The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The reasoning is pharmacological — e.g., "I will split the difference between steps" — but it is reasoning from theory, not from evidence.

29 likes in reply to #9 7mo

ppm_errorTL3Analytical chemist3 Feb 2026#30

e.silva, post #1: Micro-titration: a disputed topic, argued properly Writing it up because I had to work it out twice and would rather nobody else did. A question about technique rather than about dose. I have been doing the same thing for 19 months and it works, and then I read one of the documentation pages here and realised I may have been reasoning… Go to post

Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that very small increments are hard to measure accurately with a syringe.

28 likes in reply to #1 6mo

s.vukovicTL2 Moderator16 Feb 2026#35

Picking up post #32: that is the part I would want checked first.

Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been studied clinically. One mg of semaglutide is not equivalent to one mg of something else in any meaningful sense.

31 likes 5mo

c.kuuselaTL2 Moderator19 Mar 2026#48

Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that stepping down is followed by some regain, with the magnitude unknown.

31 likes 4mo

f.weissTL2 Moderator3 Apr 2026#55

g.amankwah, post #31: This follows post #28 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use. Go to post

27 likes in reply to #31 4mo

ms_hollowayTL4Mass spectrometrist10 May 2026#72

sharps_bin, post #36: Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound. Go to post

29 likes in reply to #36 3mo

RodriguesTL3Regular29 May 2026#81

32 likes 2mo

br.wikstromTL2 Moderator16 Jun 2026#90

Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose. Escalating before steady state means escalating on incomplete information about the dose you are on.

31 likes 1mo

Read the full topic (111 posts)

This topic was referenced in

Follow-up: Where the four-week escalation interval comes from, and what it is notPractice › Dosing & titration · 147 replies

Suggested topics

Topic	Participants	Replies	Views	Activity
Stepping down deliberately, and how to do it without losing progress — what changed since Practice › Dosing & titration tirzepatide semaglutide titration missed dose Under review Posting this under the heading it deserves: Stepping down deliberately, and how to do it without losing progress — what changed since Everything below is what sits behind that. Practical question with the…	+94	99	29k	2d
Revisiting: The arithmetic of an intermediate dose between two label steps Practice › Dosing & titration titration worked example dose reduction tirzepatide Revisiting: The arithmetic of an intermediate dose between two label steps Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I…	+41	45	808	2mo
Escalating every six weeks instead of four: what I observed over eight months Practice › Dosing & titration titration worked example dose reduction Escalating every six weeks instead of four: what I observed over eight months Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I…	+27	31	432	18mo
Escalating every six weeks instead of four: what I observed over eight months — one year on Practice › Dosing & titration missed dose semaglutide dose reduction titration On the subject in the title: Escalating every six weeks instead of four: what I observed over eight months — one year on Working notes rather than a conclusion. I have read the maintained page on this and I…	+55	59	9.1k	10mo
How the published trials escalated, tabulated side by side Practice › Dosing & titration worked example semaglutide titration dose reduction Solved Closed The question in the title: How the published trials escalated, tabulated side by side I will give what I have already checked below so nobody repeats it. A question about technique rather than about dose. I…	+4	8	4.2k	5mo

Related topics — sharing the tags titration, dose reduction, worked example

Topic	Participants	Replies	Views	Activity
What to include when your question involves arithmetic Start Here › How to Ask beginner friendly onboarding site feedback guidelines Solved Closed What to include when your question involves arithmetic — that is the question, and I have not found it answered plainly anywhere I have looked. Question in the title. Context below, and I have tried to…		2	3.1k	7mo
Revisiting: GLP-1 receptor distribution: central and peripheral Pharmacology › Receptor biology amylin analogues tirzepatide retatrutide long read Revisiting: GLP-1 receptor distribution: central and peripheral — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a…	+61	66	15k	8mo
Follow-up: Where the four-week escalation interval comes from, and what it is not Practice › Dosing & titration tirzepatide dose reduction worked example missed dose Wiki Where the four-week escalation interval comes from, and what it is not Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I still…	+131	147	47k	18mo
[2026 update] Correlation in a self-tracked dataset: what it can support Research Methods › Statistics number needed to treat effect size worked example heterogeneity Posting this under the heading it deserves: Correlation in a self-tracked dataset: what it can support Everything below is what sits behind that. I have seen SURMOUNT-4 ( JAMA , 2024) cited in support of a…		2	31k	6h
Correlation in a self-tracked dataset: what it can support Research Methods › Statistics effect size heterogeneity worked example number needed to treat Closed Correlation in a self-tracked dataset: what it can support — setting out what I have, and where I think it stops being reliable. I have seen STEP 4 ( JAMA , 2021) cited in support of a claim I do not think it…	+152	166	48k	23mo